PURPOSE: To investigate genetic determinants of macular pigment optical density in women from the Carotenoids in Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women's Health Initiative Observational Study. METHODS: 1585 of 2005 CAREDS participants had macular pigment optical density (MPOD) measured noninvasively using customized heterochromatic flicker photometry and blood samples genotyped for 440 single nucleotide polymorphisms (SNPs) in 26 candidate genes related to absorption, transport, binding, and cleavage of carotenoids directly, or via lipid transport. SNPs were individually tested for associations with MPOD using least-squares linear regression. RESULTS: Twenty-one SNPs from 11 genes were associated with MPOD (P ≤ 0.05) after adjusting for dietary intake of lutein and zeaxanthin. This includes variants in or near genes related to zeaxanthin binding in the macula (GSTP1), carotenoid cleavage (BCMO1), cholesterol transport or uptake (SCARB1, ABCA1, ABCG5, and LIPC), long-chain omega-3 fatty acid status (ELOVL2, FADS1, and FADS2), and various maculopathies (ALDH3A2 and RPE65). The strongest association was for rs11645428 near BCMO1 (βA = 0.029, P = 2.2 × 10(-4)). Conditional modeling within genes and further adjustment for other predictors of MPOD, including waist circumference, diabetes, and dietary intake of fiber, resulted in 13 SNPs from 10 genes maintaining independent association with MPOD. Variation in these single gene polymorphisms accounted for 5% of the variability in MPOD (P = 3.5 × 10(-11)). CONCLUSIONS: Our results support that MPOD is a multi-factorial phenotype associated with variation in genes related to carotenoid transport, uptake, and metabolism, independent of known dietary and health influences on MPOD.
PURPOSE: To investigate genetic determinants of macular pigment optical density in women from the Carotenoids in Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women's Health Initiative Observational Study. METHODS: 1585 of 2005 CAREDS participants had macular pigment optical density (MPOD) measured noninvasively using customized heterochromatic flicker photometry and blood samples genotyped for 440 single nucleotide polymorphisms (SNPs) in 26 candidate genes related to absorption, transport, binding, and cleavage of carotenoids directly, or via lipid transport. SNPs were individually tested for associations with MPOD using least-squares linear regression. RESULTS: Twenty-one SNPs from 11 genes were associated with MPOD (P ≤ 0.05) after adjusting for dietary intake of lutein and zeaxanthin. This includes variants in or near genes related to zeaxanthin binding in the macula (GSTP1), carotenoid cleavage (BCMO1), cholesterol transport or uptake (SCARB1, ABCA1, ABCG5, and LIPC), long-chain omega-3 fatty acid status (ELOVL2, FADS1, and FADS2), and various maculopathies (ALDH3A2 and RPE65). The strongest association was for rs11645428 near BCMO1 (βA = 0.029, P = 2.2 × 10(-4)). Conditional modeling within genes and further adjustment for other predictors of MPOD, including waist circumference, diabetes, and dietary intake of fiber, resulted in 13 SNPs from 10 genes maintaining independent association with MPOD. Variation in these single gene polymorphisms accounted for 5% of the variability in MPOD (P = 3.5 × 10(-11)). CONCLUSIONS: Our results support that MPOD is a multi-factorial phenotype associated with variation in genes related to carotenoid transport, uptake, and metabolism, independent of known dietary and health influences on MPOD.
Authors: T S Aleman; J L Duncan; M L Bieber; E de Castro; D A Marks; L M Gardner; J D Steinberg; A V Cideciyan; M G Maguire; S G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 2001-07 Impact factor: 4.799
Authors: B R Hammond; E J Johnson; R M Russell; N I Krinsky; K J Yeum; R B Edwards; D M Snodderly Journal: Invest Ophthalmol Vis Sci Date: 1997-08 Impact factor: 4.799
Authors: Julie A Mares; Tara L LaRowe; D Max Snodderly; Suzen M Moeller; Michael J Gruber; Michael L Klein; Billy R Wooten; Elizabeth J Johnson; Richard J Chappell Journal: Am J Clin Nutr Date: 2006-11 Impact factor: 7.045
Authors: Suzen M Moeller; Rick Voland; Lesley Tinker; Barbara A Blodi; Michael L Klein; Karen M Gehrs; Elizabeth J Johnson; D Max Snodderly; Robert B Wallace; Richard J Chappell; Niyati Parekh; Cheryl Ritenbaugh; Julie A Mares Journal: Arch Ophthalmol Date: 2008-03
Authors: Wei Wang; Sonja L Connor; Elizabeth J Johnson; Michael L Klein; Shannon Hughes; William E Connor Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Amy E Millen; Kristin J Meyers; Zhe Liu; Corinne D Engelman; Robert B Wallace; Erin S LeBlanc; Lesley F Tinker; Sudha K Iyengar; Jennifer G Robinson; Gloria E Sarto; Julie A Mares Journal: JAMA Ophthalmol Date: 2015-10 Impact factor: 7.389
Authors: Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Zhengqing Shen; Hassan Sharifzadeh; Brian M Besch; Kelly Nelson; Madeleine M Horvath; Jeanne M Frederick; Wolfgang Baehr; Paul S Bernstein Journal: Proc Natl Acad Sci U S A Date: 2014-06-30 Impact factor: 11.205
Authors: Sasha M Barnett; Naiman A Khan; Anne M Walk; Lauren B Raine; Christopher Moulton; Neal J Cohen; Arthur F Kramer; Billy R Hammond; Lisa Renzi-Hammond; Charles H Hillman Journal: Nutr Neurosci Date: 2017-05-23 Impact factor: 4.994
Authors: Binxing Li; Preejith P Vachali; Zhengqing Shen; Aruna Gorusupudi; Kelly Nelson; Brian M Besch; Alexis Bartschi; Simone Longo; Ty Mattinson; Saeed Shihab; Nikolay E Polyakov; Lyubov P Suntsova; Alexander V Dushkin; Paul S Bernstein Journal: Exp Eye Res Date: 2017-03-09 Impact factor: 3.467